Pacer Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History

Pacer Advisors, Inc.

$41.8 Billion
Q3 2024

A detailed history of Pacer Advisors, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 35,485 shares of BMRN stock, worth $2.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

35,485

Previous 37,332 4.95%

Holding current value

$2.2 Million

Previous $3.07 Million 18.84%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$69.02 - $93.84 $127,479 - $173,322	-1,847 Reduced 4.95%	35,485 $2.49 Million
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $2.74 Million - $3.4 Million	36,829 Added 7321.87%	37,332 $3.07 Million
Q1 2024 May 10, 2024	BUY	$83.81 - $99.0 $42,156 - $49,797	503 New	503 $43,000
Q2 2021 Jul 21, 2021	SELL	$75.51 - $84.79 $76,944 - $86,401	-1,019 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$74.73 - $90.69 $48,275 - $58,585	-646 Reduced 38.8%	1,019 $77,000
Q4 2020 Jan 20, 2021	SELL	$72.61 - $90.2 $859,121 - $1.07 Million	-11,832 Reduced 87.66%	1,665 $146,000
Q3 2020 Oct 19, 2020	SELL	$71.87 - $131.03 $50,955 - $92,900	-709 Reduced 4.99%	13,497 $1.03 Million
Q2 2020 Jul 29, 2020	SELL	$79.55 - $124.22 $29,433 - $45,961	-370 Reduced 2.54%	14,206 $1.75 Million
Q1 2020 Apr 23, 2020	BUY	$71.37 - $96.85 $86,214 - $116,994	1,208 Added 9.04%	14,576 $1.3 Million
Q4 2019 Feb 10, 2020	BUY	$64.27 - $86.37 $93,384 - $125,495	1,453 Added 12.19%	13,368 $1.13 Million
Q3 2019 Oct 10, 2019	BUY	$67.4 - $85.11 $54,863 - $69,279	814 Added 7.33%	11,915 $803,000
Q2 2019 Aug 12, 2019	BUY	$80.35 - $93.9 $90,554 - $105,825	1,127 Added 11.3%	11,101 $951,000
Q1 2019 Apr 10, 2019	BUY	$84.2 - $98.62 $839,810 - $983,635	9,974 New	9,974 $886,000
Q4 2018 Feb 13, 2019	SELL	$80.14 - $106.07 $735,685 - $973,722	-9,180 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $331,349 - $372,980	3,528 Added 62.42%	9,180 $890,000
Q2 2018 Aug 14, 2018	BUY	$76.01 - $99.03 $79,658 - $103,783	1,048 Added 22.76%	5,652 $532,000
Q1 2018 May 14, 2018	SELL	$77.67 - $92.63 $3,417 - $4,075	-44 Reduced 0.95%	4,604 $373,000
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $114,517 - $134,894	-1,418 Reduced 23.38%	4,648 $414,000
Q3 2017 Nov 08, 2017	BUY	$80.6 - $94.95 $488,919 - $575,966	6,066	6,066 $565,000

Others Institutions Holding BMRN

# of Institutions

636

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $11.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pacer Advisors, Inc. with notifications on news.

Account

Pacer Advisors, Inc. Biomarin Pharmaceutical Inc Transaction History